Ascendis Pharma A/S (ASND) NASDAQ
213.23
+7.42(+3.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11B |
| Enterprise Value | 11.26B |
| P/E Ratio | 22.49 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 13.15 |
| Price/Book Ratio | 23.32 |
| Enterprise/Revenue | 13.53 |
| Enterprise/EBITDA | -1,690.08 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.58 |
| Operating Margin | -0.01 |
Management Effectiveness
| Return On Assets | 0.25 |
| Return On Equity | -56.42 |
Income Statement
| Revenue | 691.71M |
| Revenue/Share | 14.06 |
| Gross Profit | 588.53M |
| EBITDA | -113.9M |
| Net Income | -219.03M |
| Diluted EPS | -3.62 |
Balance Sheet
| Total Cash | 573.42M |
| Total Cash/Share | 9.3 |
| Total Debt | 897.6M |
| Total Debt/Equity | 1.84 |
| Current Ratio | 1 |
| Book Value Per Share | 7.92 |
Price History
| 52-Week Change | 23.15 |
| 52-Week High | 250.74 |
| 52-Week Low | 160.86 |
| Moving Average 50 Days | 232.33 |
| Moving Average 200 Days | 216.74 |
Statistics
| Average Volume | 640,012 |
| Shares Outstanding | 61.78M |
| % Held by Institutions | 89.14 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
